Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes

Kenichi Asano1, Naomichi Takahashi2, Mikiko Ushiki2

  • 11] Laboratory of Immune regulation, School of Life Science, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan [2] Japan Science and Technology Agency, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan.

Nature Communications
|July 22, 2015
PubMed

Insights

CD169(+) macrophages in the lamina propria act as sentinels, recruiting inflammatory monocytes via CCL8 upon mucosal injury. This discovery offers a potential therapeutic target for inflammatory bowel diseases like colitis.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Lamina propria (LP) macrophages maintain tolerance to commensal bacteria via interleukin-10 (IL-10).
  • Mechanisms distinguishing bacterial invasion from commensalism are not fully understood.
  • The role of specific macrophage subsets in mucosal defense remains unclear.

Purpose of the Study:

  • To identify macrophage subsets involved in mucosal defense and inflammatory responses.
  • To elucidate the signaling pathways linking mucosal injury to monocyte recruitment.
  • To explore potential therapeutic targets for inflammatory conditions of the gut.

Main Methods:

  • Characterization of CD169(+) macrophage localization within the LP microenvironment.
  • Investigation of monocyte recruitment following mucosal injury.
  • Assessment of CCL8's role in inflammation using genetic depletion and antibody neutralization in a mouse model of colitis.

Main Results:

  • CD169(+) macrophages are located at the base of the LP, distinct from villus tip macrophages.
  • These macrophages secrete CCL8 upon mucosal injury, recruiting inflammatory monocytes.
  • Depletion of CD169(+) macrophages or anti-CCL8 treatment significantly reduced colitis symptoms in mice.

Conclusions:

  • CD169(+) macrophages represent a critical subset linking mucosal damage to inflammatory monocyte infiltration.
  • CCL8 secreted by CD169(+) macrophages acts as an alarm signal during barrier defense collapse.
  • Targeting CD169(+) macrophages or CCL8 presents a promising strategy for managing mucosal injury and inflammatory diseases.

Related Concept Videos

Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.6K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.5K